Cartaflax 76.54mg from NextGen Peptides achieves 99.85% purity according to this independent HPLC analysis with UV detection coupled to mass spectrometry. The test was conducted by Freedom Diagnostics Testing on January 11, 2026.
A purity level of 99.85% demonstrates pharmaceutical-grade synthesis with minimal contamination and high product consistency. The sample consists of multiple vials totaling the stated quantity.
The certificate of analysis (COA #2601140020) is available for download and includes chromatographic data and mass spectrometry confirmation. The sample appears as a white lyophilized powder.

Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.